6 Combat HIV/AIDS, malaria and other diseases

Where we are?


The national HIV prevalence rate among adults (15-49 years) declined from 15.6% in 2002 to 14.3% in 2007. The target, which is to keep prevalence below 15.6%, has been met. It must be noted that women in Zambia have a higher prevalence rate of 16.1% compared to men (12.3%), and the urban population has rates twice as high as the rural population (19.7% versus 10.3%). The lowering of prevalence rates has been made possible by effective strategies on ARV provision and coverage, and significant reductions in mother-to-child transmissions. Treatment for HIV patients has been scaled up to cover 70% of all PLHIV eligible for ART, while prevention efforts have increased coverage of PMTCT to 65%. The challenge remains of halving new HIV infections by 2015. The rate of contraceptive prevalence increased from 11.6% in 1992 to 24.6% in 2002. Only 25% of adult Zambians have been tested for HIV, and intensified efforts at prevention, including the use of birth control to prevent the continued spread of STDs and HIV, is key.

Important progress has been made on the malaria targets. The proportion of children under-five, who sleep under an insecticide-treated net rose from 6.5% in 2001-2002 to 41.1% in 2008. Continued efforts at access to treated bednets and malaria prophylaxis is critical to prevent any roll back of hard-won gains in this area. Tuberculosis notification rates have been declining steadily, since reaching a peak of 545 per 100,000 people in 2003-04 to 425 per 100,000 people in 2009. The target of TB treatment success rate of 85% in the new smear-positive TB patients was attained in 2007, and reached 86% in 2008.

UNDP's work in Zambia

1.28 years
remaining
until 2015

1990 2015
Targets for MDG6
  1. Halt and begin to reverse the spread of HIV/AIDS
    • HIV prevalence among population aged 15-24 years
    • Condom use at last high-risk sex
    • Proportion of population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS
    • Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years
  2. Achieve, by 2010, universal access to treatment for HIV/AIDS for all those who need it
    • Proportion of population with advanced HIV infection with access to antiretroviral drugs